These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 30187621)
21. Implications of grey zone results for routine hepatitis C virus screening with the ARCHITECT HCV-Ag assay. Arribas J; Benito R; Cebollada R; Bellés A; Bueno J; Cumbraos MJ; Gil J J Appl Microbiol; 2020 Mar; 128(3):899-906. PubMed ID: 31713922 [TBL] [Abstract][Full Text] [Related]
22. Combination hepatitis C virus antigen and antibody immunoassay as a new tool for early diagnosis of infection. Ansaldi F; Bruzzone B; Testino G; Bassetti M; Gasparini R; Crovari P; Icardi G J Viral Hepat; 2006 Jan; 13(1):5-10. PubMed ID: 16364076 [TBL] [Abstract][Full Text] [Related]
23. Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country. Otedo AE; Mc'Ligeyo SO; Okoth FA; Kayima JK S Afr Med J; 2003 May; 93(5):380-4. PubMed ID: 12830604 [TBL] [Abstract][Full Text] [Related]
24. Is hepatitis C virus core antigen an adequate marker for community screening? Kuo YH; Chang KC; Wang JH; Tsai PS; Hung SF; Hung CH; Chen CH; Lu SN J Clin Microbiol; 2012 Jun; 50(6):1989-93. PubMed ID: 22461676 [TBL] [Abstract][Full Text] [Related]
25. HCV core antigen as an alternative to HCV RNA testing in the era of direct-acting antivirals: retrospective screening and diagnostic cohort studies. van Tilborg M; Al Marzooqi SH; Wong WWL; Maan R; Vermehren J; Maasoumy B; Mazzulli T; Bolotin S; Garber G; Guerra F; Flud CR; Kowgier M; Janssen HL; de Knegt RJ; Pawlotsky JM; Cloherty GA; Duarte-Rojo A; Sarrazin C; Wedemeyer H; Feld JJ Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):856-864. PubMed ID: 30274834 [TBL] [Abstract][Full Text] [Related]
26. Design of a novel rapid immunoassay for simultaneous detection of hepatitis C virus core antigen and antibodies. Patel J; Sharma P Arch Virol; 2020 Mar; 165(3):627-641. PubMed ID: 31965313 [TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus antigen detection is an appropriate test for screening and early diagnosis of hepatitis C virus infection in at-risk populations and immunocompromised hosts. Kumar R; Chan KP; Ekstrom VSM; Wong JCC; Lim KL; Ng WC; Woo SM; Chan KS; Thangaraju S; Kee TYS; Gan SSW; Foo MWY; Oon LLE; Chow WC J Med Virol; 2021 Jun; 93(6):3738-3743. PubMed ID: 32797627 [TBL] [Abstract][Full Text] [Related]
28. Relative efficacy of nucleic acid amplification testing and serologic screening in preventing hepatitis C virus transmission risk in seven international regions. Bruhn R; Lelie N; Busch M; Kleinman S; Transfusion; 2015 Jun; 55(6):1195-205. PubMed ID: 25727549 [TBL] [Abstract][Full Text] [Related]
29. Detection of hepatitis C core antigen in the antibody negative 'window' phase of hepatitis C infection. Peterson J; Green G; Iida K; Caldwell B; Kerrison P; Bernich S; Aoyagi K; Lee SR Vox Sang; 2000; 78(2):80-5. PubMed ID: 10765142 [TBL] [Abstract][Full Text] [Related]
30. Prospective virological follow-up of hepatitis C infection in a haemodialysis unit. Halfon P; Khiri H; Feryn JM; Sayada C; Chanas M; Ouzan D J Viral Hepat; 1998 Mar; 5(2):115-21. PubMed ID: 9572036 [TBL] [Abstract][Full Text] [Related]
31. HCV viraemia in anti-HCV-negative haemodialysis patients: Do we need HCV RNA detection test? Papadopoulos N; Griveas I; Sveroni E; Argiana V; Kalliaropoulos A; Martinez-Gonzalez B; Deutsch M Int J Artif Organs; 2018 Mar; 41(3):168-170. PubMed ID: 29546809 [TBL] [Abstract][Full Text] [Related]
32. Hepatitis C virus core antigen testing: role in diagnosis, disease monitoring and treatment. Tillmann HL World J Gastroenterol; 2014 Jun; 20(22):6701-6. PubMed ID: 24944462 [TBL] [Abstract][Full Text] [Related]
33. [Prevalence of hepatitis C virus markers in Polish blood donors in 1994-2003]. Seyfried H; Brojer E; Grabarczyk P; Rosińska M; Gronowska A; Letowska M; Przegl Epidemiol; 2005; 59(4):807-14. PubMed ID: 16729421 [TBL] [Abstract][Full Text] [Related]
34. Hepatitis C virus-RNA, immunoglobulin M anti-HCV and risk factors in haemodialysis patients. Dentico P; Sacco R; Buongiorno R; Volpe A; Ranieri C; Carbone M; Carabellese S Microbios; 1999; 99(392):55-62. PubMed ID: 10624011 [TBL] [Abstract][Full Text] [Related]
35. Diagnosis and monitoring of HCV infection using the cobas Yao JD; Young S; Heilek GM; Marino E; Paxinos EE; Marins EG; Valsamakis A J Clin Virol; 2018 May; 102():63-69. PubMed ID: 29518694 [TBL] [Abstract][Full Text] [Related]
36. Recent approach for diagnosis of early HCV infection. el-Sayed Zaki M; el-Adrosy H Egypt J Immunol; 2004; 11(1):123-9. PubMed ID: 15724394 [TBL] [Abstract][Full Text] [Related]
37. Application of a new enzyme-linked immunosorbent assay for detection of total hepatitis C virus core antigen in blood donors. Cano H; Candela MJ; Lozano ML; Vicente V Transfus Med; 2003 Oct; 13(5):259-66. PubMed ID: 14617336 [TBL] [Abstract][Full Text] [Related]
38. Screening test accuracy among potential blood donors of HBsAg, anti-HBc and anti-HCV to detect hepatitis B and C virus infection in rural Cambodia and Vietnam. Bjoerkvoll B; Viet L; Ol HS; Lan NT; Sothy S; Hoel H; Gutteberg T; Husebekk A; Larsen S; Husum H Southeast Asian J Trop Med Public Health; 2010 Sep; 41(5):1127-35. PubMed ID: 21073033 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients. Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976 [TBL] [Abstract][Full Text] [Related]
40. Hepatitis C virus infection in Jordanian haemodialysis units: serological diagnosis and genotyping. Bdour S J Med Microbiol; 2002 Aug; 51(8):700-704. PubMed ID: 12171303 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]